Maley, Jason, Bruce Landon, and Jennifer Stevens. 2020. “Regional Variation in Use of End-of-Life Care at Hospitals, Intensive Care Units, and Hospices Among Older Adults With Chronic Illness in the US, 2010 to 2016”. JAMA Netw Open 3 (7): e2010810. https://doi.org/10.1001/jamanetworkopen.2020.10810.
Publications
2020
Maley, Jason, Camille Petri, Laura Brenner, Raghu Chivukula, Tiara Calhoun, Vladimir Vinarsky, and Charles Corey Hardin. (2020) 2020. “Anticoagulation, Immortality, and Observations of COVID-19”. Res Pract Thromb Haemost 4 (5): 674-76. https://doi.org/10.1002/rth2.12398.
Baker, Lawrence, Jason Maley, Aldo Arévalo, Francis DeMichele, Roselyn Mateo-Collado, Stan Finkelstein, and Leo Anthony Celi. 2020. “Real-World Characterization of Blood Glucose Control and Insulin Use in the Intensive Care Unit”. Sci Rep 10 (1): 10718. https://doi.org/10.1038/s41598-020-67864-z.
The heterogeneity of critical illness complicates both clinical trial design and real-world management. This complexity has resulted in conflicting evidence and opinion regarding the optimal management in many intensive care scenarios. Understanding this heterogeneity is essential to tailoring management to individual patients. Hyperglycaemia is one such complication in the intensive care unit (ICU), accompanied by decades of conflicting evidence around management strategies. We hypothesized that analysis of highly-detailed electronic medical record (EMR) data would demonstrate that patients vary widely in their glycaemic response to critical illness and response to insulin therapy. Due to this variability, we believed that hyper- and hypoglycaemia would remain common in ICU care despite standardised approaches to management. We utilized the Medical Information Mart for Intensive Care III v1.4 (MIMIC) database. We identified 19,694 admissions between 2008 and 2012 with available glucose results and insulin administration data. We demonstrate that hyper- and hypoglycaemia are common at the time of admission and remain so 1 week into an ICU admission. Insulin treatment strategies vary significantly, irrespective of blood glucose level or diabetic status. We reveal a tremendous opportunity for EMR data to guide tailored management. Through this work, we have made available a highly-detailed data source for future investigation.
Ziehr, David, Jehan Alladina, Camille Petri, Jason Maley, Ari Moskowitz, Benjamin Medoff, Kathryn Hibbert, Taylor Thompson, and Corey Hardin. 2020. “Respiratory Pathophysiology of Mechanically Ventilated Patients With COVID-19: A Cohort Study”. Am J Respir Crit Care Med 201 (12): 1560-64. https://doi.org/10.1164/rccm.202004-1163LE.
2019
Maley, Jason, and Taylor Thompson. 2019. “Embracing the Heterogeneity of ARDS”. Chest 155 (3): 453-55. https://doi.org/10.1016/j.chest.2018.11.016.
Maley, Jason, and Jennifer Stevens. 2019. “Post-ICU Care: If You Build It, Will They Come… and How Do You Build It?”. Crit Care Med 47 (9): 1269-70. https://doi.org/10.1097/CCM.0000000000003876.
2018
Maley, Jason, Katelyn Dannheim, Tristan Kooistra, and Robert Hallowell. 2018. “A Man With a Decade of Persistent Pulmonary Opacities”. Ann Am Thorac Soc 15 (11): 1344-48. https://doi.org/10.1513/AnnalsATS.201803-222CC.
Maley, Jason. 2018. “Hemoptysis or Hematemesis?-The Importance of Professional Medical Interpretation: A Teachable Moment”. JAMA Intern Med 178 (6): 841-42. https://doi.org/10.1001/jamainternmed.2018.0697.
2016
Maley, Jason, Isabel Brewster, Iris Mayoral, Renata Siruckova, Sarah Adams, Kelley McGraw, Angela Piech, Michael Detsky, and Mark Mikkelsen. 2016. “Resilience in Survivors of Critical Illness in the Context of the Survivors’ Experience and Recovery”. Ann Am Thorac Soc 13 (8): 1351-60. https://doi.org/10.1513/AnnalsATS.201511-782OC.
RATIONALE: Post-intensive care syndrome (PICS), defined as new or worsening impairment in cognition, mental health, or physical function after critical illness, is an important development in survivors. Although studies to date have focused on the frequency of these impairments, fundamental questions remain unanswered regarding the survivor experience and the impact of the critical illness event on survivor resilience and recovery.
OBJECTIVES: To examine the association between resilience and neuropsychological and physical function and to contextualize these findings within the survivors' recovery experience.
METHODS: We conducted a mixed-methods pilot investigation of resilience among 43 survivors from two medical intensive care units (ICUs) within an academic health-care system. We interviewed survivors to identify barriers to and facilitators of recovery in the ICU, on the medical ward, and at home, using qualitative methods. We used a telephone battery of standardized tests to examine resilience, neuropsychological and physical function, and quality of life. We examined PICS in two ways. First, we identified how frequently survivors were impaired in one or more domains 6-12 months postdischarge. Second, we identified how frequently survivors reported that neuropsychological or physical function was worse.
MEASUREMENTS AND MAIN RESULTS: Resilience was low in 28% of survivors, normal in 63% of survivors, and high in 9% of survivors. Resilience was inversely correlated with self-reported executive dysfunction, symptoms of anxiety, depression, and post-traumatic stress disorder, difficulty with self-care, and pain (P < 0.05). PICS was present in 36 survivors (83.7%; 95% confidence interval, 69.3-93.2%), whereas 23 survivors (53.5%; 95% confidence interval, 37.6-68.8%) reported worsening of neuropsychological or physical function after critical illness. We identified challenges along the recovery path of ICU survivors, finding that physical limitations and functional dependence were the most frequent challenges experienced in the ICU, medical ward, and on return to home. Spiritual and family support facilitated recovery.
CONCLUSIONS: Resilience was inversely correlated with neuropsychological impairment, pain, and difficulty with self-care. PICS was present in most survivors of critical illness, and 54% reported neuropsychological or physical function to be worse, yet resilience was normal or high in most survivors. Survivors experienced many challenges during recovery, while spiritual and family support facilitated recovery.
Maley, Jason, and Mark Mikkelsen. 2016. “Short-Term Gains With Long-Term Consequences: The Evolving Story of Sepsis Survivorship”. Clin Chest Med 37 (2): 367-80. https://doi.org/10.1016/j.ccm.2016.01.017.
Sepsis is an acute, life-threatening condition that afflicts millions of patients annually. Advances in care and heightened awareness have led to substantial declines in short-term mortality. An expanding body of literature describes the long-term impact of sepsis, revealing long-term cognitive and functional impairments, sustained inflammation and immune dysfunction, increased healthcare resource use, reduced health-related quality of life, and increased mortality. The evidence challenges the notion that sepsis is an acute, transient illness, revealing rather that sepsis is an acute illness with lingering consequences. This article provides a state-of-the-art review of the emerging literature of the long-term consequences of sepsis.
